<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-0289</journal-id>
<journal-title><![CDATA[Revista Cubana de Hematología, Inmunología y Hemoterapia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></abbrev-journal-title>
<issn>0864-0289</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Información de Ciencias MédicasEditorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-02892025000100009</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Instituto de Hematología e Inmunología: hacia la certificación en Buenas Prácticas Clínicas]]></article-title>
<article-title xml:lang="en"><![CDATA[Institute of Hematology and Immunology: Towards Certification in Good Clinical Practices]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruiz Villegas]]></surname>
<given-names><![CDATA[Laura]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Forrellat Barrios]]></surname>
<given-names><![CDATA[Mariela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto de Hematología e Inmunología  ]]></institution>
<addr-line><![CDATA[ La Habana]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>41</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-02892025000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-02892025000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-02892025000100009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Las Buenas Prácticas Clínicas (BPC) son un conjunto de normas internacionales, que se aplican y respetan en todo el mundo, diseñadas para proteger a los sujetos y garantizar la integridad de los ensayos clínicos. El Instituto de Hematología en Inmunología (IHI), es un centro de atención terciaria que desde hace años ha estado vinculado al desarrollo de ensayos clínicos, pero hasta el momento no se ha certificado por BPC. En esta comunicación se abordan los principales aspectos que justifican el proceso de esta certificación en el IHI. Se realiza un breve acercamiento al proceso de certificación de Buenas Prácticas Clínicas a partir de la Regulación número 52-2008 del CECMED; la función del CENCEC en el diagnóstico del cumplimiento de los requisitos para la preparación con vistas a la certificación y se expone la experiencia acumulada en el instituto que hacen que esté en condiciones de iniciar el proceso de preparación para la Certificación en BPC.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Good Clinical Practices (GCP) are a set of international standards, applied and respected worldwide, designed to protect subjects and ensure the integrity of clinical trials. The Institute of Hematology in Immunology (IHI) is a tertiary care center that has been involved in the development of clinical trials for years, but has not yet been certified by GCP. This communication addresses the main aspects that justify the process of this certification at the IHI. In this communication is made a brief approach to the certification process of Good Clinical Practices based on Regulation number 52-2008 of the CECMED; the role of the CENCEC in the diagnosis of compliance with the requirements for preparation for certification and the accumulated experience in the institute that makes it in a position to begin the preparation process for Certification in GCP.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[buenas prácticas clínicas]]></kwd>
<kwd lng="es"><![CDATA[ensayos clínicos]]></kwd>
<kwd lng="es"><![CDATA[instituto de hematología e inmunología]]></kwd>
<kwd lng="en"><![CDATA[good clinical practice]]></kwd>
<kwd lng="en"><![CDATA[clinical trials]]></kwd>
<kwd lng="en"><![CDATA[institute of hematology in immunology]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>SafetyCulture</collab>
<article-title xml:lang=""><![CDATA[Good Clinical Practice: An Introduction]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Altomonte]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Explicación de las buenas prácticas clínicas]]></source>
<year>22/0</year>
<month>7/</month>
<day>20</day>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Resolución Ministerial 177 (versión corregida)]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Méndez Triana]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Rivas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Botello Ramírez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Certificación de Buenas Prácticas Clínicas: necesidad de preparar los sitios clínicos y los servicios involucrados en ensayos clínicos para alcanzar esta condición]]></article-title>
<source><![CDATA[Acta Méd Centro]]></source>
<year>2015</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>CECMED</collab>
<source><![CDATA[Resolución CECMED No. 119/2008: Regulación No. 52-2008 Requerimientos para la Certificación de Buenas Prácticas Clínicas. Ámbito Regulador]]></source>
<year>2008</year>
<page-range>00-76</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz Villegas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Forrellat Barrios]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Ensayos Clínicos en el Instituto de Hematología e Inmunología: doce años de experiencias y desafíos]]></source>
<year>2023</year>
<publisher-name><![CDATA[Congreso Hematología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barceló]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento con células madre autólogas en pacientes recuperados de la COVID-19 con lesiones pulmonares]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></source>
<year></year>
<page-range>37</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viada González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo Luaces]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes Espinosa]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lage Dávila]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[Consuelo Macías]]></given-names>
</name>
<name>
<surname><![CDATA[Simón Pita]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictive Variables of Lung Damage in Recovered Covid-19 Patients]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Bouza-Herrera]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
</person-group>
<source><![CDATA[Modelling Experiences of the COVID-19 Pandemic in Ibero-America]]></source>
<year>2023</year>
<publisher-loc><![CDATA[UK ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge Scholars Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Macías Abraham]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Porto González]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Legrá Ayala]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Forrellat Barrios]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lam Díaz]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Cordoví Rodríguez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Convalescent plasma therapy prevents acute respiratory distress syndrome in patients with SARS-CoV-2 virus disease]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter. 27]]></source>
<year></year>
<page-range>36</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Verez-Bencomo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa-Azze]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[García-Rivera]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Climent-Ruiz]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Valdés-Balbín]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chang-Monteagudo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[SOBERANA®Plus: refuerzo seguro y eficaz de la inmunidad natural preexistente contra SARS-CoV-2]]></article-title>
<source><![CDATA[Anales de la Academia de Ciencias de Cuba]]></source>
<year>2023</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang-Monteagudo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa-Azze]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Climent-Ruiz]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Macías-Abraham]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Noda]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Valenzuela-Silva]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile An open-label phase 1 clinical trial]]></article-title>
<source><![CDATA[Lancet Reg Health Am]]></source>
<year>2021</year>
<volume>4</volume>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ochoa-Azze]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chang-Monteagudo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Climent-Ruiz]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Macías-Abraham]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Valenzuela-Silva]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial]]></article-title>
<collab>de Los Ángeles García-García M</collab>
<source><![CDATA[Lancet Respir Med]]></source>
<year>2022</year>
<volume>10</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>785-95</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
